Recurrent Primary Peritoneal Cavity Cancer
Also known as: Recurrent Primary Peritoneal Cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB11793 | Niraparib | A poly-ADP ribose polymerase inhibitor used to treat recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer responding to platinum based chemotherapy. |
DB12332 | Rucaparib | A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat recurrent ovarian and prostate cancers in previously treated adults. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00995 | Auranofin | 0 | Completed | 1 |
DB02594 | 2'-Deoxycytidine | 1 | Completed | 1 |
DB00958 | Carboplatin | 1 | Completed | 2 |
DB00958 | Carboplatin | 1 | Withdrawn | 1 |
DB01262 | Decitabine | 1 | Completed | 1 |
DB00997 | Doxorubicin | 1 | Completed | 1 |
DB00441 | Gemcitabine | 1 | Completed | 2 |
DB17475 | Incomplete Freund's adjuvant | 1 | Completed | 1 |
DB00331 | Metformin | 1 | Withdrawn | 1 |
DB00834 | Mifepristone | 1 | Completed | 1 |
DB17498 | NY-ESO-1 peptide vaccine | 1 | Completed | 1 |
DB01229 | Paclitaxel | 1 | Withdrawn | 1 |
DB00020 | Sargramostim | 1 | Completed | 2 |
DB00877 | Sirolimus | 1 | Completed | 1 |
DB14707 | Cemiplimab | 1 / 2 | Recruiting | 1 |
DB11717 | Epacadostat | 1 / 2 | Withdrawn | 1 |
DB12047 | Ganetespib | 1 / 2 | Terminated | 1 |
DB01229 | Paclitaxel | 1 / 2 | Terminated | 1 |
DB11767 | Sarilumab | 1 / 2 | Recruiting | 1 |
DB03496 | Alvocidib | 2 | Completed | 1 |
DB04849 | Cediranib | 2 | Completed | 1 |
DB00515 | Cisplatin | 2 | Completed | 1 |
DB05076 | Fenretinide | 2 | Completed | 1 |
DB00441 | Gemcitabine | 2 | Completed | 1 |
DB00331 | Metformin | 2 | Suspended | 1 |
DB11965 | SJG-136 | 2 | Terminated | 1 |
DB00398 | Sorafenib | 2 | Completed | 1 |
DB01268 | Sunitinib | 2 | Completed | 1 |
DB11800 | Tivozanib | 2 | Completed | 1 |
DB00135 | Tyrosine | 2 | Completed | 1 |